Patents by Inventor Stephen E. Goldstone

Stephen E. Goldstone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD AND SYSTEM FOR CONFIDENTIALLY PROVIDING ACCURATE SEXUALLY TRANSMITTED DISEASE INFORMATION
    Publication number: 20140142985
    Abstract: A method for confidentially providing STD information is provided. The method includes receiving at least one first identifying datum uniquely identifying a first person; receiving at least one first STD datum of the first person; receiving at least one second identifying datum uniquely identifying a second person; receiving at least one second STD datum of the second person; providing electronically the first identifying datum and the first STD datum to a requestor authorized by the first person; and providing electronically the second identifying datum and the second STD datum to a further requestor authorized by the second person. A computerized system for confidentially providing STD information is also provided.
    Type: Application
    Filed: November 21, 2013
    Publication date: May 22, 2014
    Inventors: Bruce O. Karp, Stephen E. Goldstone
  • Human papilloma virus treatment
    Patent number: 7754449
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Grant
    Filed: April 26, 2007
    Date of Patent: July 13, 2010
    Assignee: Nventa Biopharmaceuticals Corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Patent number: 7211411
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Grant
    Filed: June 18, 2004
    Date of Patent: May 1, 2007
    Assignee: Nventa Biopharmaceuticals Corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Publication number: 20040235741
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: June 18, 2004
    Publication date: November 25, 2004
    Applicant: Stressgen Biotechnologies Corporation, a Canadian corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Patent number: 6797491
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Grant
    Filed: February 13, 2003
    Date of Patent: September 28, 2004
    Assignee: Stressgen Biotechnologies Corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Publication number: 20030170268
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: February 13, 2003
    Publication date: September 11, 2003
    Applicant: Stressgen Biotechnologies Corporation, a Canadian corporation
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux
  • Human papilloma virus treatment
    Publication number: 20020110566
    Abstract: Disclosed is a method of treating a wart in a subject by administering to the subject a composition containing (1) a heat shock protein or an immunostimulatory fragment thereof, and (2) a protein of a human papilloma virus or an antigenic fragment thereof. Also disclosed is a method of treating a human papilloma virus infection in a subject infected or suspected of being infected with a human papilloma virus of a first type by administering to the subject a composition containing (1) a heat shock protein or an antigenic fragment thereof, and (2) a protein of a human papilloma virus of a second type or an antigenic fragment thereof, where the first type and second type are different.
    Type: Application
    Filed: June 26, 2001
    Publication date: August 15, 2002
    Inventors: John R. Neefe, Stephen E. Goldstone, Mark T. Winnett, Marvin Siegel, Leslie J. Boux